Pharmacokinetic characterization of the indole alkaloid ibogaine in rats

Methods and Findings in Experimental and Clinical Pharmacology

Volumn 22, Issue 2, 2000, Pages 77-81

  Hough, Lindsay B ^a   Bagal, A A ^a   Glick, S D ^a  

^a ALBANY MEDICAL COLLEGE   (United States)

Author keywords

Addiction; Ibogaine; Noribogaine; Pharmacokinetics

Indexed keywords

ALKALOID; IBOGAINE; INDOLE DERIVATIVE; NORIBOGAINE;

ADIPOSE TISSUE; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DEMETHYLATION; DRUG BLOOD LEVEL; DRUG BRAIN LEVEL; DRUG CLEARANCE; DRUG DEPENDENCE; DRUG HALF LIFE; NONHUMAN; RAT;

EID: 0034078732     PISSN: 03790355     EISSN: None     Source Type: Journal    
DOI: 10.1358/mf.2000.22.2.796066     Document Type: Article

References (12)

1. Glick, S.D., Rossman, K., Steindorf, S., Maisonneuve, I.M., Carlson, J.N. Effects and aftereffects of ibogaine on morphine self-administration in rats. Eur J Pharmacol 1991, 195: 341-5.
2. Rezvani, A.H., Overstreet, D.H., Lee, Y. Attenuation of alcohol intake by ibogaine in three strains of alcohol-preferring rats. Pharmacol Biochem Behav 1995, 52: 615-20.
3. Cappendijk, S.L.T., Dzoljic, M.R. Inhibitory effects of ibogaine on cocaine self-administration in rats. Eur J Pharmacol 1993, 241: 261-5.
4. Maisonneuve, I.M., Keller, R.W., Glick, S.D. Interactions between ibogaine, a potential anti-addictive agent, and morphine: An in vivo microdialysis study. Eur J Pharmacol 1991, 199: 35-42.
5. Mash, D.C., Staley, J.K., Baumann, M.H., Rothman, R.B., Hearn, W.L. Identification of a primary metabolite of ibogaine that targets serotonin transporters and elevates serotonin. Life Sci 1995, 57: PL45-50.
6. Pearl, S.M., Hough, L.B., Boyd, D.L., Glick, S.D. Sex differences in ibogaine antagonism of morphine and in ibogaine brain levels and metabolism. Pharmacol Biochem Behav 1996, 57: 809-15.
7. Pearl, S.M., Herrick-Davis, K., Teitler, M., Glick, S.D. Radioligund-binding study of noribogaine, a likely metabolite of ibogaine. Brain Res 1995, 675: 342-4.
8. Hough, L.B., Pearl, S.M., Glick, S.D. Tissue distribution of ibogaine after intraperitoneal and subcutaneous administration. Pharmacol Lett 1996, 58: PL119-22.
9. Gallagher, C.A., Hough, L.B., Keefner, S.M., Syed-Mozafarri, A., Archer, S., Glick, S.D. Identification and quantification of the indole alkaloid ibogaine in biological samples by gas chromatography-mass spectrometry. Biochem Pharmacol 1995, 49: 73-9.
10. D'Argenio, D.Z., Schumitzky, A. ADAPT II. A Program for Simulation, Identification and Optimal Experimental Design. User Manual. Biomedical Simulations Resource, University of Southern California: Los Angeles, 1992.
11. Hearn, W.L., Pablo, J., Hime, G.W., Mash, D.C. Identification and quantitation of ibogaine and an O-demethylaled metabolite in brain and biological fluids using gas chromatography-mass spectrometry. J Analyt Toxicol 1995, 19: 427-34.
12. Ley, F.R., Jeffcoat, A.R., Thomas, B.F. Determination of ibogaine in plasma by gas chromatography-chemical ionization mass spectrometry. J Chromatogr 1996, 723: 101-9.